Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Immunotherapy|November 11, 2021
Delayed immune-related neutropenia with hepatitis by pembrolizumabSoichiro Nakako, Yasuhiro Nakashima, Hiroshi Okamura, et al.
International Journal of Hematology|April 7, 2026
Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective studyKumiyo Tazoe, Hirohisa Nakamae, Yosuke Makuuchi, et al.
Cell Transplantation|July 30, 2022
A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological MalignanciesHirohisa Nakamae, Hiroshi Okamura, Asao Hirose, et al.
International Journal of Hematology|July 26, 2021
Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopeniaTetsuya Hayashi, Hirohisa Nakamae, Shinichi Takeda, et al.
International Journal of Hematology|September 28, 2019
Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patientsTakahiko Nakane, Hiroshi Okamura, Yumi Tagaito, et al.
Annals of Hematology|April 25, 2024
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemiaKumiyo Tazoe, Naonori Harada, Yosuke Makuuchi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 18, 2016
Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disordersHideo Koh, Mizuki Aimoto, Takako Katayama, et al.
International Journal of Hematology|September 29, 2021
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantationHirohisa Nakamae, Takahiko Nakane, Hiroshi Okamura, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Mogamulizumab Concentration-guided Allogeneic Transplantation and Successful Intrathecal Chemotherapy for Central Nervous System-relapsed Adult T-cell Leukemia/LymphomaSaki Fujii, Kazuki Sakatoku, Yosuke Nakaya, et al.
Transplant Immunology|January 7, 2024
Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioningMasatomo Kuno, Hideo Koh, Kentaro Ido, et al.
Pageof 6